NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 52 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $33,000 | -21.4% | 62,669 | 0.0% | 0.00% | – |
| Q2 2020 | $42,000 | +16.7% | 62,669 | 0.0% | 0.00% | – |
| Q1 2020 | $36,000 | -78.0% | 62,669 | -50.0% | 0.00% | – |
| Q4 2019 | $164,000 | +31.2% | 125,338 | +100.0% | 0.00% | – |
| Q3 2019 | $125,000 | -17.8% | 62,669 | 0.0% | 0.00% | – |
| Q2 2019 | $152,000 | +33.3% | 62,669 | +34.1% | 0.00% | – |
| Q1 2019 | $114,000 | -16.2% | 46,739 | -50.0% | 0.00% | – |
| Q4 2018 | $136,000 | +7.9% | 93,478 | +100.0% | 0.00% | – |
| Q3 2018 | $126,000 | -22.2% | 46,739 | 0.0% | 0.00% | – |
| Q2 2018 | $162,000 | +170.0% | 46,739 | +286.6% | 0.00% | – |
| Q1 2018 | $60,000 | -16.7% | 12,089 | 0.0% | 0.00% | – |
| Q4 2017 | $72,000 | -27.3% | 12,089 | 0.0% | 0.00% | – |
| Q3 2017 | $99,000 | – | 12,089 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
| Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |